ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines

British Journal of Cancer

Volumn 103, Issue 5, 2010, Pages 715-726

  Ayoub, C ^a   Wasylyk, C ^a   Li, Y ^a   Thomas, E ^b   Marisa, L ^b   Robe A ^a   Roux, M ^a   Abecassis, J ^c   De Reynies A ^b   Wasylyk, B ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b Programme Cartes d'Identite des Tumeurs   (France)

^c CENTRE PAUL STRAUSS   (France)

Author keywords

ANO1; CaCC; cell movement; distant metastasis; HNSCC

Indexed keywords

CALCIUM CHANNEL; CHLORIDE CHANNEL; PROTEIN ANO1; UNCLASSIFIED DRUG;

AMPLICON; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTION; CELL PROLIFERATION; CELL SPREADING; CONTROLLED STUDY; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; METASTASIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 77955983967     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605823     Document Type: Article

References (60)

1. Akervall JA, Jin Y, Wennerberg JP, Zatterstrom UK, Kjellen E, Mertens F, Willen R, Mandahl N, Heim S, Mitelman F (1995) Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 76: 853-859
2. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP (1997) Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79: 380-389
3. Berenson JR, Koga H, Yang J, Pearl J, Holmes EC, Figlin R (1990) Frequent amplification of the bcl-1locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group. Oncogene 5: 1343-1348
4. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905
5. Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, Widaa S, Hinton J, Fahey C, Fu B, Swamy S, Dalgliesh GL, Tch BT, Deloukas P, Yang F, Campbell PJ, Futreal PA, Stratton MR (2010) Signatures of mutation and selection in the cancer genome. Nature 463: 893-898
6. Borg A, Sigurdsson H, Clark GM, Ferno M, Fuqua SA, Olsson H, Killander D, McGurie WL (1991) Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br J Cancer 63: 136-142
7. Bregestovski P, Waseem T, Mukhtarov M (2009) Genetically encoded optical sensors for monitoring of intracellular chloride and chloride-selective channel activity. Front Mol Neurosci 2: 15
8. Caputo A, Caci E, Ferrera L, Pedemonte N, Barsanti C, Sondo E, Pfeffer U, Ravazzolo R, Zegarra-Moran O, Galietta LJ (2008) TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 322: 590-594
9. Carles A, Millon R, Cromer A, Ganguli G, Lemaire F, Young J, Wasylyk C, Muller D, Schultz I, Rabouel Y, Dembele D, Zhao C, Marchal P, Ducray C, Bracco L, Abecassis J, Poch O, Wasylyk B (2006) Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene 25: 1821-1831
10. Dobrossy L (2005) Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 24: 9-17
11. Espinosa I, Lee CH, Kim MK, Rouse BT, Subramanian S, Montgomery K, Varma S, Corless CL, Heinrich MC, Smith KS, Wang Z, Rubin B, Nielsen TO, Seitz RS, Ross DT, West RB, Cleary ML, Van De Rijn M (2008) A novel monoclonal antibody against DOG1is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol 32: 210-218
12. Ferrera L, Caputo A, Ubby I, Bussani E, Zegarra-Moran O, Ravazzolo R, Pagani F, Galietta LJ (2009) Regulation of TMEM16A chloride channel properties by alternative splicing. J Biol Chem 284(48): 33360-33368
13. Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345: 1890-1900
14. Galindo BE, Vacquier VD (2005) Phylogeny of the TMEM16 protein family: some members are overexpressed in cancer. Int J Mol Med 16: 919-924
15. Gibcus JH, Kok K, Menkema L, Hermsen MA, Mastik M, Kluin PM, Van Der Wal JE, Schuuring E (2007) High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications. Hum Genet 121: 187-201
16. Gibcus JH, Mastik MF, Menkema L, De Bock GH, Kluin PM, Schuuring E, Van Der Wal JE (2008) Cortactin expression predicts poor survival in laryngeal carcinoma. Br J Cancer 98: 950-955
17. Gollin SM (2001) Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 23: 238-253
18. Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359: 1143-1154
19. Heino J, Kapyla J (2009) Cellular receptors of extracellular matrix molecules. Curr Pharm Des 15: 1309-1317
20. Henson BJ, Bhattacharjee S, O Dee DM, Feingold E, Gollin SM (2009) Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 48: 569-582
21. Huang X, Godfrey TE, Gooding WE, McCarty Jr KS, Gollin SM (2006) Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer 45: 1058-1069
22. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A (1994) PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54: 4813-4817
23. Jarvinen AK, Autio R, Kilpinen S, Saarela M, Leivo I, Grenman R, Makitie AA, Monni O (2008) High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosomes Cancer 47: 500-509
24. Jiang L, Zeng X, Yang H, Wang Z, Shen J, Bai J, Zhang Y, Gao F, Zhou M, Chen Q (2008) Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma. Int J Cancer 123: 1779-1786
25. Jung AC, Briolat J, Millon R, De Reynies A, Rickman D, Thomas E, Abecassis J, Clavel C, Wasylyk B (2010) Biological and clinical relevance of transcriptionnally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer 126: 1882-1894
26. Katoh M, Katoh M (2003) FLJ10261 gene, located within the CCND1-EMS1locus on human chromosome 11q13, encodes the eight-transmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products. Int J Oncol 22: 1375-1381
27. Katoh M, Katoh M (2004) Characterization of human TMEM16G gene in silico. Int J Mol Med 14: 759-764
28. Kitagawa Y, Ueda M, Ando N, Shinozawa Y, Shimizu N, Abe O (1991) Significance of int-2/hst-1coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res 51: 1504-1508
29. Klussmann JP, Mooren JJ, Lehnen M, Claessen SM, Stenner M, Huebbers CU, Weissenborn SJ, Wedemeyer I, Preuss SF, Straetmans JM, Manni JJ, Hopman AH, Speel EJ (2009) Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15: 1779-1786
30. Kunzelmann K (2005) Ion channels and cancer. J Membr Biol 205: 159-173
31. Kunzelmann K, Kongsuphol P, Aldehni F, Tian Y, Ousingsawat J, Warth R, Schreiber R (2009) Bestrophin and TMEM16-Ca(2+) activated Cl(-) channels with different functions. Cell Calcium 46: 233-241
32. Le Tourneau C, Velten M, Jung GM, Bronner G, Flesch H, Borel C (2005) Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621cases. Head Neck 27: 801-808
33. Lemaire F, Millon R, Young J, Cromer A, Wasylyk C, Schultz I, Muller D, Marchal P, Zhao C, Melle D, Bracco L, Abecassis J, Wasylyk B (2003) Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 89: 1940-1949
34. Mao JW, Wang LW, Jacob T, Sun XR, Li H, Zhu LY, Li P, Zhong P, Nie SH, Chen LX (2005) Involvement of regulatory volume decrease in the migration of nasopharyngeal carcinoma cells. Cell Res 15: 371-378
35. Martin CL, Reshmi SC, Ried T, Gottberg W, Wilson JW, Reddy JK, Khanna P, Johnson JT, Myers EN, Gollin SM (2008) Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol 44: 369-382
36. Michalides R, Van Veelen N, Hart A, Loftus B, Wientjens E, Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978
37. Michalides RJ, Van Veelen NM, Kristel PM, Hart AA, Loftus BM, Hilgers FJ, Balm AJ (1997) Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 123:497-502
38. Parikh RA, White JS, Huang X, Schoppy DW, Baysal BE, Baskaran R, Bakkenist CJ, Saunders WS, Hsu LC, Romkes M, Gollin SM (2007) Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 46: 761-775
39. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
40. Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49: 33-64, 1
41. Perez-Ordonez B, Beauchemin M, Jordan RC (2006) Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 59: 445-453
42. Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, Gollin SM (2006) 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 95: 1432-1438
43. Rath A, Glibowicka M, Nadeau VG, Chen G, Deber CM (2009) Detergent binding explains anomalous SDS-PAGE migration of membrane proteins. Proc Natl Acad Sci USA 106: 1760-1765
44. Reshmi SC, Huang X, Schoppy DW, Black RC, Saunders WS, Smith DI, Gollin SM (2007) Relationship between FRA11F and 11q13 gene amplification in oral cancer. Genes Chromosomes Cancer 46: 143-154
45. Rickman DS, Millon R, De Reynies A, Thomas E, Wasylyk C, Muller D, Abecassis J, Wasylyk B (2008) Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene 27: 6607-6622
46. Rock JR, Futtner CR, Harfe BD (2008) The transmembrane protein TMEM16A is required for normal development of the murine trachea. Dev Biol 321: 141-149
47. Rodrigo JP, Garcia-Carracedo D, Garcia LA, Menendez S, Allonca E, Gonzalez MV, Fresno MF, Suarez C, Garcia-Pedrero JM (2009) Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 217: 516-523
48. Rodrigo JP, Gonzalez MV, Lazo PS, Ramos S, Coto E, Alvarez I, Garcia LA, Suarez C (2002) Genetic alterations in squamous cell carcinomas of the hypopharynx with correlations to clinicopathological features. Oral Oncol 38: 357-363
49. Rodrigues SP, Fathers KE, Chan G, Zuo D, Halwani F, Meterissian S, Park M (2005) CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells. Mol Cancer Res 3: 183-194
50. Ruoslahti E, Obrink B (1996) Common principles in cell adhesion. Exp Cell Res 227: 1-11
51. Schroeder BC, Cheng T, Jan YN, Jan LY (2008) Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 134: 1019-1029
52. Schultz BD, Singh AK, Devor DC, Bridges RJ (1999) Pharmacology of CFTR chloride channel activity. Physiol Rev 79: S109-S144
53. Serra-Pages C, Medley QG, Tang M, Hart A, Streuli M (1998) Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. J Biol Chem 273: 15611-15620
54. Staaf J, Lindgren D, Vallon-Christersson J, Isaksson A, Goransson H, Juliusson G, Rosenquist R, Hoglund M, Borg A, Ringner M (2008) Segmentation-based detection of allelic imbalance and loss-of-hetero-zygosity in cancer cells using whole genome SNP arrays. Genome Biol 9: R136
55. Tchou-Wong KM, Fok SY, Rubin JS, Pixley F, Condeelis J, Braet F, Rom W, Soon LL (2006) Rapid chemokinetic movement and the invasive potential of lung cancer cells; a functional molecular study. BMC Cancer 6: 151
56. Verkman AS, Galietta LJ (2009) Chloride channels as drug targets. Nat Rev Drug Discov 8: 153-171
57. Webb DJ, Parsons JT, Horwitz AF (2002) Adhesion assembly, disassembly and turnover in migrating cells-over and over and over again. Nat Cell Biol 4: E97-100
58. Werner MH, Wu C, Walsh CM (2006) Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation. Cell Cycle 5: 2332-2338
59. West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Brown PO, Heinrich MC, Van De Rijn M (2004) The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165: 107-113
60. Yang YD, Cho H, Koo JY, Tak MH, Cho Y, Shim WS, Park SP, Lee J, Lee B, Kim BM, Raouf R, Shin YK, Oh U (2008) TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 455: 1210-1215